TOI M, LLC
CIK 1892968 · last filed 2025-06-09
TOI M, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $6.9M of TOIIW on Jun 9, 2025. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. The firm reports its address in Boston, MA. 5 SEC filings were submitted jointly with M33 Growth I GP LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TOIIW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 500
BOSTON, MA 02199-8202
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. (TOIIW) Delisted | Director | 15,223,281 | $0.05 | $745.9K | -$6.86M | 1 | 2025-06-09 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-09 | Oncology Institute, Inc. (TOIIW) Delisted | Sell (S) | −2,250,000 | -$6.86M | EDGAR |
| 2025-06-05 | TOI | Notice (144) | −127,207 | -$407.1K | EDGAR |
| 2025-05-20 | TOI | Notice (144) | −203,532 | -$622.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.